Clinical Trials
19 trialsNCT03234335 2023-05-06
IRMYG
Centre Hospitalier Universitaire de Saint Etienne
Completed
NCT01575925 2022-11-04
POM Renal
Celgene
Phase 1 Completed
NCT02921802 2022-06-14
A Study of Special Use Results Surveillance of Revlimid 5mg Capsules
Celgene
Completed
NCT02922543 2022-06-14
A Safety and Efficacy Study of Revlimid® 5 mg Capsules in Patients With Relapsed or Refractory Multiple Myeloma Who Have Received Long-term Treatment With it Under the Actual Condition of Use
Celgene
Completed
NCT02424851 2022-01-27
OPTIMAL
Oxford University Hospitals NHS Trust
Phase 2 Completed
NCT02045017 2021-08-27
Efficacy and Safety of Pomalidomide and Dexamethasone in RRMM Patients With Renal Insufficiency
Celgene
Phase 2 Completed
NCT01337752 2020-12-17
Study in Patients With Untreated Multiple Myeloma and Renal Insufficiency
Novartis
Phase 2 Completed
NCT00854139 2020-03-04
Combined Bone Marrow Transplantation (BMT) and Renal Transplant for Multiple Myeloma (MM) With End Stage Renal Disease (ESRD)
Massachusetts General Hospital
Phase 1 Completed
NCT00652626 2019-11-19
RENAL
Celgene
Phase 1 Completed
NCT01447914 2019-08-28
Tivantinib in Treating Patients With Relapsed, or Relapsed and Refractory Multiple Myeloma
National Cancer Institute (NCI)
Phase 2 Completed
NCT01270932 2017-12-29
Lenalidomide & High Dose Dexamethasone for Untreated Multiple Myeloma Renal Failure Patients
University Health Network, Toronto
Phase 2 Completed
NCT00721734 2017-05-02
Study of the Safety and Pharmacokinetics of Carfilzomib in Patients With Relapsed and Refractory Multiple Myeloma and Varying Degrees of Renal Function
Amgen
Phase 2 Completed
NCT00434447 2017-02-27
Long Term Efficacy and Safety of Zoledronic Acid Treatment in Patients With Bone Metastases
Novartis
Phase 4 Completed
NCT00779922 2016-10-11
Pharmacokinetics of Lenalidomide (Revlimid®) in Patients With Multiple Myeloma and Impaired Renal Function
Poitiers University Hospital
Phase 2 Completed
NCT00700531 2016-10-05
EuLITE
University Hospital Birmingham
Phase NA Completed
NCT01084837 2015-09-17
RENVEL
PETHEMA Foundation
Phase 2 Completed
NCT00416897 2013-08-26
Dexamethasone and Chemotherapy With or Without Plasma Exchange in Patients With Newly Diagnosed Multiple Myeloma and Acute Kidney Failure
National Cancer Institute (NCI)
Phase 3 Completed
NCT00062621 2013-02-05
Combined Bone Marrow and Kidney Transplant for Multiple Myeloma With Kidney Failure
National Institute of Allergy and Infectious Diseases (NIAID)
Phase 1 Completed
NCT00401804 2013-01-24
Bortezomib-Dexamethasone-Doxorubicin-Study
Austrian Forum Against Cancer
Phase 2 Completed